Organization

NYU Hospital for Joint Diseases, New York

5 abstracts

Abstract
A DESCRIPTIVE ANALYSIS OF REAL-WORLD TREATMENT PATTERNS OF INNOVATOR INFLIXIMAB (REMICADE) AND BIOSIMILAR INFLIXIMAB IN A TREATMENT NAÏVE TURKISH RHEUMATOLOGIC DISEASE POPULATION
Org: NYU Hospital for Joint Diseases, New York, STATinMED Research Inc, Ann Arbor, Janssen Scientific Affairs, LLC, Horsham, United States, Guven Hospital, Ankara, Turkey,
Abstract
A COMPOSITE INDEX OF PHYSICAL FUNCTION, PAIN, PATIENT GLOBAL AND JOINT COUNT, RAPID4 (ROUTINE ASSESSMENT OF PATIENT INDEX DATA): VIRTUALLY IDENTICAL RESULTS WITH A PATIENT SELF-REPORT OR PHYSICIAN/ASSESSOR JOINT COUNT OR NO JOINT COUNT IN RAPID3
Org: Medicine and Frontier Science Center of Disease Molecular Network, Vanderbilt University Medical Center, Nashville, Arthritis & Rheumatology, Taylor Hospital,
Abstract
A TRANSLATION TEMPLATE FOR PATIENT SELF-REPORT MEDICAL HISTORY AND FUNCTIONAL STATUS QUESTIONNAIRE IN A FIXED, STANDARD 4-PAGE FORMAT TO FACILITATE TRANSLATION WHEN A HEALTH PROFESSIONAL AND PATIENT DO NOT SPEAK THE SAME LANGUAGE
Org: Medicine and Frontier Science Center of Disease Molecular Network, Vanderbilt University Medical Center, NYU Hospital for Joint Diseases, New York,
Abstract
AN INDEX WITHOUT FORMAL JOINT COUNTS, ROUTINE ASSESSMENT OF PATIENT INDEX DATA (RAPID3), TO HELP GUIDE TIGHT CONTROL OF RA IN STANDARD CARE: MOST PATIENTS WHO MEET DAS OR CDAI REMISSION OR HIGH ACTIVITY CRITERIA MEET IDENTICAL PRELIMINARY RAPID CRITERIA
Org: Medicine, Kuopio University Hospital, Kuopio, Vanderbilt University Medical Center, Nashville, Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, NYU Hospital for Joint Diseases, New York,